RNA-mediated pathogenic mechanisms in polyglutamine diseases and amyotrophic lateral sclerosis by Ho Yin Edwin Chan
CELLULAR NEUROSCIENCE
REVIEW ARTICLE
published: 19 December 2014
doi: 10.3389/fncel.2014.00431
RNA-mediated pathogenic mechanisms in polyglutamine
diseases and amyotrophic lateral sclerosis
Ho Yin Edwin Chan1,2*
1 Laboratory of Drosophila Research, School of Life Sciences, Faculty of Science, The Chinese University of Hong Kong, Hong Kong, China
2 Biochemistry Programme, School of Life Sciences, Faculty of Science, The Chinese University of Hong Kong, Hong Kong, China
Edited by:
Rosanna Parlato, Ulm University,
Germany
Reviewed by:
Maciej Figiel, Polish Academy of
Sciences, Poland
Michal Hetman, KSCIRC, USA
*Correspondence:
Ho Yin Edwin Chan, Laboratory of
Drosophila Research and
Biochemistry Programme, School of
Life Sciences, Faculty of Science,
The Chinese University of Hong
Kong, Room 509B, Mong Man Wai
Building, Shatin N.T.,
Hong Kong, China
e-mail: hyechan@cuhk.edu.hk
Gene transcription produces a wide variety of ribonucleic acid (RNA) species in eukaryotes.
Individual types of RNA, such as messenger, structural and regulatory RNA, are known
to play distinct roles in the cell. Recently, researchers have identified a large number
of RNA-mediated toxicity pathways that play significant pathogenic roles in numerous
human disorders. In this article, we describe various common RNA toxicity pathways,
namely epigenetic gene silencing, nucleolar stress, nucleocytoplasmic transport, bi-
directional gene transcription, repeat-associated non-ATG translation, RNA foci formation
and cellular protein sequestration. We emphasize RNA toxicity mechanisms that involve
nucleotide repeat expansion, such as those related to polyglutamine (polyQ) disorders and
frontotemporal lobar degeneration-amyotrophic lateral sclerosis.
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INTRODUCTION
Ribonucleic acids (RNAs) are polymeric macromolecules
composed of a wide variety of nucleotide building blocks.
Various classes of RNA have been reported to date, of which
major examples are messenger RNAs (mRNAs), ribosomal RNAs
(rRNAs), transfer RNAs, and non-coding RNAs. Each RNA class
is distinct in terms of synthesis, properties and functions. It is
widely acknowledged that most RNAs have cellular roles in gene
regulation and protein translation. However, a few RNAs are
known to have less common functions such as serving as genetic
materials for RNA viruses. In cells, RNAs are transcribed by RNA
polymerase according to sequences on the DNA template. A
subset of RNAs is further modified through various processing
steps such as cleavage, base modification and editing. Such
modifications are crucial to the generation of mature and fully
functional RNA molecules.
In addition to the well-established roles of various classes
of RNA molecules in neuronal (Iyengar et al., 2014) and brain
(Follert et al., 2014) development, many RNAs are known to
be involved in neural pathologies (Cooper et al., 2009). Recent
investigations have provided a more thorough understanding of
the pathogenic roles of RNAs in neurological disorders. The dys-
regulation of the cellular processes that govern RNA metabolism
is now known to contribute to neuronal dysfunctions and dis-
eases. Such perturbation may be caused by the alteration of
RNA transcription, splicing, editing and/or nuclear export due
to genetic predisposition or as a consequence of normal aging
(Cooper et al., 2009; Da Cruz and Cleveland, 2011; Johnson et al.,
2012; Singh, 2012; Belzil et al., 2013b; Nalavade et al., 2013;
Caillet-Boudin et al., 2014). Genome microsatellite instability,
particularly nucleotide repeat expansion, has been shown to
cause a number of human genetic diseases (Mirkin, 2007), many
of which are neurological diseases such as amyotrophic lateral
sclerosis (ALS), Huntington’s Disease (HD) and spinocerebellar
ataxias (SCAs; Figure 1; Cruts et al., 2013; Nalavade et al., 2013;
Tsoi and Chan, 2014). The toxic effect of nucleotide repeat
expansion has been demonstrated to be caused by to a gain-
of-function mechanism. Mutant RNA molecules that harbor
expanded repeat sequences tend to form intracellular RNA foci,
which are pathogenic hallmark of many of the diseases listed
above (Wojciechowska and Krzyzosiak, 2011). The involvement of
many RNA-binding proteins in human diseases is unsurprising,
as RNAs often take the form of ribonucleoprotein complexes in
cells (Lukong et al., 2008). Protein sequestration and RNA foci
formation have been reported to play important roles in the gain-
of-function pathogenic mechanisms that produce neuronal RNA
toxicity. Mutant RNAs may also interfere with gene transcrip-
tion via RNA-mediated gene silencing mechanisms (Colak et al.,
2014). In addition, mutant RNAs may confer neurotoxicity at
the protein level through a repeat-associated non-ATG translation
mechanism (Cleary and Ranum, 2014). In this review, recent
advances in research on the above mentioned RNA toxicity mech-
anisms will be discussed.
NUCLEOTIDE REPEAT EXPANSION AS A PATHOGENIC
MECHANISM OF NEURODEGENERATION
In 1991, the mutations causing fragile-X syndrome (Kremer
et al., 1991; Verkerk et al., 1991) and spinobulbar muscular
atrophy/Kennedy’s disease (La Spada et al., 1991) were iden-
tified. Incidentally, the molecular pathogenic mechanisms of
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FIGURE 1 | Select diseases that display RNA repeat expansion-mediated toxicities.
both diseases stem from the inter-generational expansion of
genomic triplet nucleotide repeat sequences. To date, more than
20 neurological diseases have been reported to be caused by
microsatellite sequence expansion mechanism (Polak et al., 2013),
such as HD (Macdonald, 1993), several types of spinocerebellar
ataxia (Rüb et al., 2013) and frontotemporal lobar degeneration-
amyotrophic lateral sclerosis (DeJesus-Hernandez et al., 2011;
Renton et al., 2011; Gijselinck et al., 2012; Figure 1). We now
know that repeat-expansion mutation is closely associated with
the unique structural features of repetitive DNA sequences, and
perturbs cellular DNA replication, repair and recombination
(Mirkin, 2007).
ASSOCIATION BETWEEN PATHOGENIC PATHWAYS AND
CAG REPEAT EXPANSION IN THE PROTEIN-CODING REGION
The expansion of CAG trinucleotide repeats in the protein-
coding regions of the human genome is the pathogenic mech-
anism for many neurological diseases (Nalavade et al., 2013).
Protein translation leads to the production of proteins that harbor
expanded stretches of glutamine amino acid residues. Various
mouse models of polyglutamine (polyQ) diseases have been
developed (Figiel et al., 2012) to examine the role of expanded
polyQ proteins in disease pathogenesis. Since the beginning of
the new millennium, Drosophila disease models have offered an
alternative means of investigating the genetic pathogenic path-
ways involved in nucleotide-expansion diseases (McLeod et al.,
2005), such as polyQ diseases (Chan and Bonini, 2000; Yu and
Bonini, 2011). To investigate the pathogenic role of expanded
CAG sequences at the RNA level, Li et al. (2008) expressed an
artificial DsRed reporter that carried an expanded allele of CAG
sequence located in the 3′ untranslated region of the transgene
in the nervous system, and observed neurodegeneration in the
retina and the brain. Intriguingly, toxicity was reduced when the
CAG repeat continuity of the mutant allele was intermittently
disrupted by a CAA codon. This indicates that the repeat conti-
nuity of CAG triplets is essential to RNA toxicity (Li et al., 2008).
Expanded CAG RNA toxicity was also observed in Caenorhab-
ditis elegans (Wang et al., 2011a) and mouse (Hsu et al., 2011)
models.
EXPANDED CAG RNA PATHOGENIC MECHANISMS
ALTERNATIVE SPLICING OF RNAs
Expanded CAG RNAs form foci in cell and animal models, and
in patient cells (Li et al., 2008; de Mezer et al., 2011; Hsu et al.,
2011; Wang et al., 2011a; Wojciechowska and Krzyzosiak, 2011).
Muscleblind-like (MBNL) proteins are a group of RNA-binding
proteins that contain four zinc-finger domains, and are involved
in the regulation of RNA alternative splicing (Konieczny et al.,
2014). Artificial expanded CAG RNA binds to MBNL1 with a high
affinity (∼11 nM, as determined by filter-binding assay; Yuan
et al., 2007). It was reported that MBNL1 protein sequestered
to CAG RNA foci formed by artificial CAG, ataxin-3 (ATXN3)
and huntingtin (htt) transcripts (de Mezer et al., 2011; Hsu et al.,
2011; Mykowska et al., 2011; Wang et al., 2011a). A group of
MBNL1-regulated genes examined in cell models demonstrated
alternative splicing alterations, such as neuronal cell lines that
expressed expanded CAG constructs and SCA3 patient fibroblasts
(Mykowska et al., 2011). The overexpression of MBNL1 may
partially restore artificial expanded CAG RNA-induced alternative
splicing defects in Mykowska et al. (2011). This demonstrates
a correlation between MBNL1 recruitment to CAG RNA foci
and MBNL1 dysfunction in the RNA toxicity of polyQ dis-
eases (Figure 2). However, alternative splicing defects were not
observed in an in vivo DsRed-CAG270 transgenic Drosophila model
(Li et al., 2008). The overexpression of MBNL ortholog in a C.
elegans expanded CAG RNA model may partially mitigate the
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FIGURE 2 | CAG triplet repeat RNA causes aberrant RNA splicing.
expanded artificial CAG RNA phenotype of transgenic worms
(Wang et al., 2011a).
TOXICITY OF HAIRPIN AND DOUBLE-STRANDED CAG REPEAT RNAs
In addition to alternative splicing defects, small CAG RNAs
are responsible for HD toxicity (Bañez-Coronel et al., 2012;
Figure 3). Although these CAG RNA repeat sequences do not
form foci in cells, they bind MBNL1 with an affinity similar
to that of long CAG RNAs (Mykowska et al., 2011). Unex-
panded short CAG repeat RNAs (sRNAs), such as (CAG)7 or
(CAG)20, have been shown to induce alternative splicing defects
in mammalian cells (Mykowska et al., 2011). More recently,
Bañez-Coronel et al. (2012) detected htt small RNAs compris-
ing approximately seven CAG repeats in cell models, mouse
HD disease models and patient brain samples. The production
of such sRNAs causes caspase activation and cytotoxicity and
the number of CAG-repeat sRNAs is dependent on the CAG
repeat length (Bañez-Coronel et al., 2012). Dicer is a RNase
III family ribonuclease responsible for cleaving double-stranded
precursor RNAs to generate sRNAs, and plays a key role in RNA
interference (Bernstein et al., 2001). Expanded CAG RNAs form
double-stranded RNA hairpins with A-A mismatches (Sobczak
et al., 2003; Kiliszek et al., 2010; de Mezer et al., 2011; Busan
and Weeks, 2013; Yildirim et al., 2013). Bañez-Coronel et al.
(2012) showed that expanded CAG RNAs are good substrates
of Dicer. A knockdown of Dicer expression reduces the level of
CAG sRNAs in HD and SCA type 1 (Krol et al., 2007; Bañez-
Coronel et al., 2012), which further indicates the involvement
of RNAi machinery in the production of CAG sRNAs. Cleaved
sRNAs participate in posttranscriptional gene silencing. The
role of CAG sRNAs in RNA interference relies on their ability
to interact with complementary CUG RNA tracts in cellular
RNAs. The genes MEIS2 and ADORA2 have also been reported
to be down-regulated in HD, and their transcripts have been
predicted to form RNA duplexes with CAG sRNAs (Hodges
et al., 2006). The overexpression of CAG sRNAs in cells reduces
endogenous levels of MEIS2 and ADORA2 (Bañez-Coronel et al.,
2012). This explains the role of CAG sRNAs in silencing cellu-
lar gene expression in CAG triplet repeat expansion diseases in
general.
In addition to expanded CAG hairpin RNA, the transgenic
expression of two complementary expanded CAG and CUG RNA
sequences in the Drosophila eye causes deleterious external eye
morphology (Lawlor et al., 2011; Yu et al., 2011). In contrast
with CAG RNAs which adopt a double-stranded RNA hairpin
structure with A-A mismatches (Sobczak et al., 2003; Kiliszek
et al., 2010; de Mezer et al., 2011; Busan and Weeks, 2013;
Yildirim et al., 2013), duplex CAG/CUG RNAs are expected to
form perfectly-matched double-stranded CAG-CUG RNAs. In
addition, Lawlor et al. showed that neither the expression of
CAG nor CUG RNA elicits toxicity in flies (Lawlor et al., 2011),
and that the rough eye phenotype induced by CAG-CUG co-
expression was dependent on Dicer activity (Lawlor et al., 2011;
Yu et al., 2011; Figure 3). sRNAs were reported in flies expressing
single-stranded CAG hairpin RNAs and CAG-CUG duplex RNAs
(Lawlor et al., 2011). However, CAG sRNAs were observed to be
more prominent in the CAG-CUG dsRNA-expressing flies. At the
molecular level, Lawlor et al. (2011) also detected altered miRNA
levels in the CAG-CUG dsRNA-expressing flies. It is worth noting
that miRNAs have been implicated in neurodegeneration (Abe
and Bonini, 2013).
NUCLEOLAR STRESS AND RNA TOXICITY
The results of a biochemical study conducted by our group
indicate that in contrast with unexpanded CAG transcripts (both
ATXN3 and artificial CAG RNA), RNAs that carry expanded CAG
repeats are enriched in the nuclear fraction (Tsoi et al., 2011). This
finding suggests that nucleocytoplasmic transport of the mutant
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FIGURE 3 | CAG triplet repeat RNA leads to gene silencing.
RNAs is perturbed. A follow-up genetic investigation using
Drosophila model identified U2AF50, Drosophila ortholog of U2
small nucleoprotein auxiliary factor 65 (U2AF65; Blanchette et al.,
2004), as a genetic modifier of expanded CAG RNA nucleocy-
toplasmic localization. The export of unexpanded ATXN3 and
pure CAG repeat transcripts was not affected. Knockdown of
U2AF50 expression in flies was found to intensify the neu-
rodegenerative phenotype in flies (Tsoi et al., 2011). Tsoi et al.
also identified a ribonucleoprotein complex consisting of mutant
ATXN3 RNA, U2AF65 and nuclear RNA export factor 1 in mam-
malian cells. This complex is responsible for mediating mutant
RNA export. Knockdown of U2AF65 expression in cells leads
to the nuclear retention of mutant ATXN3 RNA and triggers
caspase activation (Tsoi et al., 2011). This finding confirms the
involvement of the nucleus in expanded CAG RNA toxicity.
Interestingly, the results of a HD mouse model study indicate
that the level of developmental expression of U2AF65 decreases
with age, and that this decline attenuates the nuclear export
of mutant htt RNAs (Tsoi et al., 2011). This suggests that the
nuclear accumulation of mutant htt RNA is a direct conse-
quence of developmental decline in the cellular abundance of
U2AF65, which coincides with the progressive degeneration of
HD.
Within the nuclear compartment, expanded CAG RNAs,
including ATXN3, co-localize the nucleolar protein fibrillarin
(Tsoi et al., 2012), suggesting that mutant RNAs interfere
with nucleolar function (Figure 4). The cell nucleolus is the
site of production of ribosome subunits, and the dysregula-
tion of ribosome biogenesis has been shown to cause disease
(Kressler et al., 2010). RNA polymerase I is responsible for
the transcription of rRNA precursors (pre-rRNAs). rRNA is
an essential component of the ribosome, a ribonucleoprotein
complex responsible for protein translation. The inhibition of
pre-rRNA transcription has been shown to cause apoptosis
in neurons (Kalita et al., 2008). “Nucleolar stress” denotes
the cellular pathway used by the nucleolus to communicate
with cytosolic compartments (Boulon et al., 2010), such as
the mitochondria (Lindenboim et al., 2011) and thereby ini-
tiate apoptosis. It is a universal and efficient mechanism for
eliminating cells that are defective in protein synthesis due
to ribosome biogenesis failure. Our group recently demon-
strated a link between nucleolar stress and RNA toxicity in
polyQ diseases, including SCA type 3 and HD (Tsoi et al.,
2012; Tsoi and Chan, 2013, 2014). We found that nucleolin
(NCL), a nucleolar protein that regulates rRNA transcription
(Durut and Sáez-Vásquez, 2014), interacts directly and specif-
ically with expanded CAG RNAs, and that such binding is
mediated by the RNA-recognition motifs of NCL (Tsoi et al.,
2012). This RNA/protein interaction prevents NCL protein from
binding to the upstream control element (UCE) of the rRNA
promoter, which results in UCE DNA hypermethylation. This
leads to the down-regulation of rRNA transcription. We fur-
ther showed that p53 protein becomes stabilized in cells and
concentrated in the mitochondria. This causes the release of
cytochrome c from the mitochondria, caspase activation and
apoptosis induction (Tsoi et al., 2012). Although restoring the
efficient nuclear export of mutant RNAs would alleviate nucle-
olar stress-mediated RNA toxicity (Tsoi and Chan, 2014), the
exported cytosolic expanded CAG RNAs could cause the syn-
thesis of expanded polyQ disease protein which might in turn
trigger protein-mediated toxicity in cells (Williams and Paulson,
2008). To ensure a suitable therapeutic treatment for polyQ
diseases, both RNA and protein toxicities must be effectively
handled.
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FIGURE 4 | CAG triplet repeat RNA induces nucleolar stress.
BI-DIRECTIONAL TRANSCRIPTION AND REPEAT-ASSOCIATED
NON-ATG TRANSLATION OF CAG EXPANSION TRANSCRIPTS
Bi-directional transcription has been reported in the human
genome, yielding both sense and anti-sense transcripts of com-
plementary sequences. The anti-sense transcripts are now known
to play important regulatory roles in eukaryotic gene expres-
sion (Faghihi and Wahlestedt, 2009). Spinocerebellar ataxia
type 8 (SCA8) is caused by a CTG.CAG repeat expansion
in the 3′ untranslated region of the ataxin-8 gene (ATXN8;
Figure 5; Koob et al., 1999). On gene transcription, the
CAG-containing ATXN8 and CUG-containing ATXN8 oppo-
site strand (ATXN8OS) transcripts were detected in SCA8
patients (Moseley et al., 2006), and nuclear CUG ATXN8OS
foci were found in HEK293 cells (Chen et al., 2009), the
SCA8 mouse model and SCA8 patients (Daughters et al.,
2009). Further, ribonuclear ATXN8OS foci were found to
be co-localized with MBNL1 and displayed an alternative
splicing pattern in both SCA8 mice and SCA8 patients
(Daughters et al., 2009), demonstrating a gain-of-function role
for expanded CUG ATXN8OS RNA in the pathogenesis of
SCA8.
Under normal physiological conditions, protein synthesis is
mediated by ATG initiation codon-dependent mRNA transla-
tion. Recently, Zu et al. (2011) discovered a repeat expansion-
associated non-ATG translation (RAN) mechanism that facilitates
protein synthesis in repeat expansion diseases. Interestingly, when
an ATXN8 transgene carrying a mutated ATG initiation codon
was expressed in HEK293 cells, the CAG-containing region of
the mutant ATXN8 CAG transcripts was still able to produce
protein products carrying a polyQ, a polyalanine or a polyser-
ine domain (Zu et al., 2011). These homopolymeric proteins
were translated from all three different reading frames of the
ATG-defective ATXN8 transcripts through the RAN mechanism
(Figure 5). Long CAG repeat-containing transcripts are prone
to frameshift error during protein translation and have been
reported to cause the production of polyalanine and polyser-
ine proteins in HD mouse model and HD patients (Davies
and Rubinsztein, 2006), and polyalanine proteins in SCA3
patients (Gaspar et al., 2000). Both in vitro and in vivo analyses
showed that these homopolymeric proteins are toxic and thus
play a role in pathogenesis (Zu et al., 2011; van Eyk et al.,
2012).
NON-TRANSLATING EXPANDED CAG REPEAT SEQUENCES
UP-REGULATE GENE TRANSCRIPTION
Spinocerebellar ataxia type 12 is caused by the expansion of
CAG triplet sequences in exon 7 of the brain-specific regu-
latory subunit of the protein phosphatase 2A gene PPP2R2B
which constitutes part of the non-coding region of the gene
(Holmes et al., 1999). The PPP2R2B promoter, which carries
an expanded CAG allele, demonstrated greater transcriptional
activity (Lin et al., 2010), and the transgenic overexpression of
the human PPP2R2B gene in Drosophila caused neurodegen-
eration (Wang et al., 2011b), indicating that, in addition to
glutamine-coding CAG triplet expansion, non-translating CAG
repeat sequences can cause toxicity via the up-regulation of gene
expression.
DOUBLE-STRANDED RNA-DEPENDENT PROTEIN KINASE BINDS
MUTANT htt TRANSCRIPTS AND ITS ACTIVITY IS INDUCED IN HD
Protein kinase R (PKR), also known as double-stranded RNA-
dependent protein kinase, regulates protein translation by
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FIGURE 5 | RNA-mediated pathogenic pathways that associate with spinocerebellar ataxia type 8.
mediating the protein phosphorylation of eukaryotic initiation
factor 2α (eIF2α; Marchal et al., 2014). Double-stranded RNAs,
such as viral RNAs, have been shown to be the main activa-
tors of PKR. Expanded CAG transcripts, including htt and the
androgen receptor (for spinobulbar muscular atrophy) RNAs,
were reported to form double-stranded hairpin structures (de
Mezer et al., 2011; Busan and Weeks, 2013). When in vitro
transcribed biotinylated mutant htt RNA was incubated with
human brain extracts, PKR was identified as the htt RNA-
binding protein (Peel et al., 2001), demonstrating that htt tran-
scripts are able to interact with PKR. The autophosphoryla-
tion of PKR is an indication of its activation (Marchal et al.,
2014), and phospho-PKR immunoreactivity was detected in a
HD transgenic mouse model and HD patients (Peel et al., 2001;
Bando et al., 2005). As PKR activation causes the phospho-
rylation of eIF2α and subsequently leads to the induction of
apoptosis (Peel, 2004), the binding of mutant htt transcripts to
PKR may serve as a trigger to initiate neuronal cell death in
HD.
OTHER PATHWAYS
The results of recent genome-wide microarray and genetic
analyses (Shieh and Bonini, 2011; van Eyk et al., 2011) have
shown that in addition to alternative splicing (Mykowska et al.,
2011), mRNA down-regulation (Bañez-Coronel et al., 2012),
miRNA alteration (Lawlor et al., 2011) and nucleolar stress
(Tsoi et al., 2012; Tsoi and Chan, 2013), other gene path-
ways are responsible for expanded CAG RNA toxicity. How-
ever, detailed mechanisms of these pathways are yet to be fully
elucidated.
ASSOCIATION BETWEEN PATHOGENIC PATHWAYS AND
GGGGCC REPEAT EXPANSION IN NON PROTEIN-CODING
REGIONS
The expansion of non-coding GGGGCC repeats in a gene named
Chromosome 9 open reading frame 72 (C9orf72) has been identi-
fied as a cause of ∼40% of hereditary ALS and 25% of familial
frontotemporal dementia (FTD) cases. Together, these conditions
are generally termed C9FTD/ALS (DeJesus-Hernandez et al.,
2011; Renton et al., 2011). Recent findings indicate that gain-of-
function toxicity contributes significantly to C9FTD/ALS patho-
genesis. Here, we discuss some recent advances in RNA-mediated
gain-of-function toxicity in C9FTD/ALS (Figure 6).
INFLUENCE OF EPIGENETIC REGULATION AND G-QUADRUPLEX DNA
FORMATION ON C9orf72 GENE EXPRESSION
The C9orf72 gene product belongs to the guanine nucleotide
exchange factor protein family and has been implicated in intra-
cellular membrane trafficking (Zhang et al., 2012; Levine et al.,
2013). The down-regulation of C9orf72 gene expression leads to
toxicity due to a loss-of C9orf72 function in C9FTD/ALS. The
GGGGCC-repeat region lies between two alternatively spliced
non-coding exons of the C9orf72 gene (DeJesus-Hernandez et al.,
2011; Belzil et al., 2013a). The findings of various independent
studies indicate that the expression level of C9orf72 transcripts is
reduced in C9FTD/ALS patients (DeJesus-Hernandez et al., 2011;
Gijselinck et al., 2012; Belzil et al., 2013a; Fratta et al., 2013).
Recently, Waite et al. (2014) detected a reduction in C9ORF72
protein levels in C9FTD/ALS patients with the GGGGCC repeat
expansion. This finding further supports the hypothesis that
C9FTD/ALS entails a loss-of-protein function.
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FIGURE 6 | RNA-mediated pathogenic pathways that associate with GGGGCC hexanucleotide repeat expansion in C9FTD/ALS.
Post-translation modifications of the core histone proteins,
H3 and H4, are known to modulate gene regulation. Trimethy-
lation of H3 and H4 core histones at particular lysine residues
are associated with gene silencing (Barski et al., 2007). Belzil
et al. (2013a) showed that the gene expression level of C9orf72
was reduced in patients who presented with H3K9, H3K27,
H3K79 and H4K20 trimethylation. In addition to histone
modifications, the intrinsic biophysical properties of C9orf72
GGGGCC hexanucleotide repeat sequences also help to reduce
the gene expression of C9or72. The appearance of four con-
secutive guanine nucleotides in DNA, such as in the case of
GGGGCC in C9orf72, leads to the formation of a meta-stable
DNA secondary structure termed a G-quadruplex (Haeusler
et al., 2014). The formation of G-quadruplex DNA has been
shown to play regulatory roles in various cellular processes,
such as gene transcription control (Lam et al., 2013). Haeusler
et al. (2014) recently demonstrated that the formation of
GGGGCC DNA G-quadruplex structure halts the transcrip-
tion of C9orf72, which provides an alternative explanation for
the down-regulation of C9orf72 gene expression observed in
C9FTD/ALS.
C9orf72 RNA FOCI AND CELLULAR PROTEIN SEQUESTRATION
C9orf72 RNA containing GGGGCC repeats has been reported
to form RNA foci (DeJesus-Hernandez et al., 2011; Almeida
et al., 2013; Donnelly et al., 2013; Gendron et al., 2013; Lagier-
Tourenne et al., 2013; Mizielinska et al., 2013; Sareen et al.,
2013; Zu et al., 2013). Mizielinska et al. (2013) also iden-
tified an inverse correlation between RNA foci and age-at-
onset of C9FTD/ALS. Biochemical and microscopic investigations
showed that C9orf72 RNA is capable of recruiting cellular
proteins to RNA foci (reviewed by Vatovec et al., 2014). Among
these proteins are RNA-binding proteins such as hnRNPs (Lee
et al., 2013; Mori et al., 2013b; Sareen et al., 2013) and
RNA export factors (Sareen et al., 2013; Cooper-Knock et al.,
2014). The recruitment of these proteins to C9orf72 RNA foci
compromises their cellular functions, leading to C9FTD/ALS
pathologies.
RECRUITMENT OF CELLULAR COMPONENTS TO C9orf72 DNA AND RNA
G-QUADRUPLEXES
G-quadruplex structures (Haeusler et al., 2014) have been
detected in DNAs and RNAs (Kikin et al., 2008). Recently,
GGGGCC repeat sequences have been found to promote the for-
mation of C9orf72 RNA G-quadruplex (Fratta et al., 2012), whose
structure is sequence- and GGGGCC repeat length-dependent
(Reddy et al., 2013). Haeusler et al. (2014) identified a series of
cellular proteins that interact specifically with GGGGCC RNA
G-quadruplexes (Haeusler et al., 2014). The direct interaction
of nucleolar protein NCL with GGGGCC RNA G-quadruplexes
was confirmed (Durut and Sáez-Vásquez, 2014). More impor-
tantly, the subcellular localization of NCL was found to be
altered in patient cells, and NCL was shown to become more
diffusely localized outside the nucleolar region in cells expressing
expanded GGGGCC C9orf72 RNA (Haeusler et al., 2014). The
subcellular mislocalization of NCL also affects pre-rRNA pro-
cessing in patient cells. This finding is indicative of nucleolar
stress activation (Boulon et al., 2010), and provides a direct
molecular link between C9orf72 GGGGCC RNA G-quadruplexes
and C9FTD/ALS toxicity. In addition to NCL, GGGGCC G-
quadruplex DNA and RNA structures have also recently been
reported to possess heme-binding activity (Grigg et al., 2014).
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Heme is composed of ferrous iron and protoporphyrin, and
serves as a prosthetic group of many cellular proteins, such as
redox enzymes. Its role in neurodegeneration is well illustrated
in Alzheimer’s Disease. Amyloid beta peptide has been found
to bind with heme (Atamna and Frey, 2004), leading to heme
deficiency (Atamna et al., 2001). It is obvious that the recruit-
ment of cellular components to GGGGCC G-quadruplex struc-
tures triggers neurotoxicity in C9FTD/ALS via various pathogenic
pathways.
BI-DIRECTIONAL TRANSCRIPTION AND REPEAT-ASSOCIATED
NON-ATG TRANSLATION OF C9orf72
Although GGGGCC repeat expansion is located in non-coding
exon of C9orf72 (DeJesus-Hernandez et al., 2011; Belzil et al.,
2013a), Mori et al. (2013a) showed that GGGGCC repeats are
transcribed bi-directionally. More recently, both the sense and
anti-sense GGGGCC C9orf72 transcripts have been reported
to generate five different dipeptide repeat (DPR)-containing
proteins composed of GA, GP, GR, PR and AP amino acid
repeats (Ash et al., 2013; Gendron et al., 2013; Mori et al.,
2013a,c; Zu et al., 2013) via the RAN mechanism (Zu et al.,
2011). Microscopic DPR protein aggregates have been detected
in C9FTD/ALS patients (Liu et al., 2014; May et al., 2014;
Proudfoot et al., 2014). It has been shown that DPR pro-
tein aggregates are heterogeneous in nature, and co-localize
with cellular proteins such as the proteasome degradation
marker p62 (Mackenzie et al., 2013; Mann et al., 2013;
Mori et al., 2013a,c; May et al., 2014), ubiquitin (Zhang
et al., 2014) and transport factor Unc119 (May et al., 2014).
The co-localization of cellular proteins to DPR aggregates is
expected to cause varying degrees of loss-of-function in the
cellular proteins, which in turn contributes to C9FTD/ALS
pathogenesis.
The neurotoxicity of DPR proteins is determined by their
subcellular localization and by the sequestration of cellular pro-
teins to DPR aggregates. Kwon et al. (2014) demonstrated that
the nucleolar localization of DPR aggregates impairs pre-rRNA
biogenesis and causes cell death. The results from an inde-
pendent study conducted by Zhang et al. (2014) indicate that
cytosolic DPR aggregates impair the ubiquitin-proteasome sys-
tem (UPS) and induce ER stress. As both the UPS and ER
stress pathways are involved in protein homeostasis, these find-
ings highlight the role of protein misfolding in C9FTD/ALS.
In addition to cell culture models, Drosophila models have
been used to demonstrate the neurotoxicity of DPR polypep-
tides (Mizielinska et al., 2014). In other words, DPR protein
toxicity has been confirmed using an in vivo animal disease
model.
THERAPEUTIC DEVELOPMENT TO COMBAT NUCLEOTIDE
REPEAT EXPANSION RNA TOXICITY
Based on our current understanding of nucleotide repeat
expansion disease pathogenesis pathways, various therapeu-
tic approaches have been developed. Oligonucleotide-based
therapeutics (Fiszer and Krzyzosiak, 2014) such as antisense
oligonucleotides (ASOs) have been shown to reduce C9or72
RNA expression and foci formation (Donnelly et al., 2013;
Lagier-Tourenne et al., 2013; Sareen et al., 2013), and thereby
to reduce RNA toxicity in C9FTD/ALS. Small molecules capa-
ble of targeting toxic RNA-protein interaction can pharmaco-
logically correct splicing defects associated with sequestration
of MBNL1 in expanded CAG RNA (Kumar et al., 2012), and
hnRNPA1 in expanded GGGGCC C9orf72 RNA (Zamiri et al.,
2014). In addition, another class of small molecules that target
GGGGCC RNAs has been reported to be capable of reducing
RNA foci formation and RAN-mediated DPR protein produc-
tion (Su et al., 2014) in C9FTD/ALS. Prior to clinical trials,
animal disease models will be used to test these novel com-
pounds and approaches. It is expected that the identification
of more nucleotide repeat expansion pathogenic pathways will
enable more therapeutic approaches to be developed in the
future.
OUTLOOK
Although protein toxicity was considered to play a major role
in the pathogenesis of repeat expansion diseases, we now know
that mutant transcripts also induce cell dysfunction and death via
multiple mechanisms, such as the alteration of gene expression
levels and splicing patterns, the generation of small RNAs, the
induction of nucleolar stress, the promotion of bi-directional
transcription and repeat-associated non-ATG translation of the
disease locus, the activation of apoptotic signaling, and the
sequestration of cellular components to RNA foci. The above
RNA-mediated mechanisms are predicted to operate in conjunc-
tion with the protein-mediated pathways to confer overall neu-
rotoxicity. We now know that mutant RNAs confer cytotoxicity
by sequestering cellular components to RNA foci (Wojciechowska
and Krzyzosiak, 2011). The identification of the individual polyQ
protein species, including the monomer, oligomer, protofibril,
fibril and inclusion body, has greatly facilitated the study of
polyQ protein toxicity (Hands and Wyttenbach, 2010). Tech-
nologies and strategies that result in a detailed classification of
individual mutant RNA species will allow more in-depth and
systematic investigations of the RNA-mediated pathogenesis of
neurodegeneration.
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